Report Highlights
The global market for smart medical devices reached $56.4 billion in 2021 and should reach more than $122.8 billion in 2026, with a compound annual growth rate (CAGR) of 16.8% during the forecast period of 2021-2026.
Report Includes
- 14 data tables and 14 additional tables
- An updated overview of the global market for smart medical devices within the industry
- Analyses of the global market trends, with historic market revenue (sales data) for 2019-2021, and projections of compound annual growth rates (CAGRs) through 2026
- Highlights of the current and future market potential for smart medical devices, and areas of focus to forecast this market into various segments and sub-segments
- Evaluation and forecast the global market size for smart medical devices, projected growth trends, and corresponding market share analysis by product type, application, and geographic region
- Technology assessment of the key drivers, restraints and opportunities that will shape the market over the next five years (2021 to 2026)
- Analysis of market opportunities with detailed Porter’s five forces analysis for the smart medical devices market
- In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Company profiles of major players within the industry, including Abbott, Boston Scientific Corp., F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., Medtronic and Novo Nordisk
Report Scope
This report will provide detailed exposure to the smart medical devices market, analyzing the market trends with data from 2020, estimates from 2021, projections of compound annual growth rates through 2026 (forecast period 2021-2026), and regional markets. The report highlights smart medical devices’ current and future market potential and offers a detailed analysis of the competitive environment, covering regulatory scenarios, drivers, restraints, and opportunities. The report also
covers market projections for 2026 and market share for key market players.
The market has been segmented based on product type, application, and geography. Based on product type, the market in this report is segmented into wearable, non-wearable, and implantable medical devices. The applications of smart medical devices considered in this report include cardiovascular, diabetes, neurology, sleep disorders, and others.
The regional market analysis of smart medical devices is also covered in this report. The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, and the Rest of the World (RoW) regions. Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Japan, China, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2020 because of the base year, with estimates for 2021 and forecast value for 2026.
*Note: The report’s scope includes smart devices that are medically accepted and approved in the market and excludes smart trackers such as smart watches, wristband sensors, eye-wearing smart glasses, smart belts, earrings, earphones, headphones, gloves, shoes, baseball caps, bras, arm bands, scarfs, and many others.
Report Synopsis
Report Metrics | Details | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2021 | ||||||||||||||||||||||||||
Forecast period considered | 2026 | ||||||||||||||||||||||||||
Base year market size | $51.6 billion | ||||||||||||||||||||||||||
Market size forecast | $122.8 billion | ||||||||||||||||||||||||||
Growth rate | CAGR of 16.8% for the forecast period of 2021-2026 | ||||||||||||||||||||||||||
Units considered | $ Millions | ||||||||||||||||||||||||||
Segments covered | products, applications and region | ||||||||||||||||||||||||||
Regions covered | North America, Europe, Asia-Pacific, and the Rest of the World (RoW) | ||||||||||||||||||||||||||
Countries covered | U.S., Canada, Germany, France, U.K., Italy, Spain, China, India, Japan, and South Korea | ||||||||||||||||||||||||||
Key Market Drivers |
|
||||||||||||||||||||||||||
Companies studied |
|
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- The Global Market for Composites: Resins, Fillers, Reinforcements, Natural Fibers and Nanocomposites (PLS029H)
- Alzheimer's Disease Therapeutics and Diagnostics: Global Markets (PHM062E)
- Impact Modifiers: Global Markets (AVM252A)
- Adhesives and Adhesive-Applying Equipment: Technologies and Global Markets (CHM073E)
- Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
Related Reports
Brain-Computer Interface: Global Markets
The global market for brain computer interface (BCI) was valued at $2.1 billion in 2023. The market is expected to grow from $2.3 billion in 2024 to $4.5 billion by 2029, at a compound annual growth rate (CAGR) of 14.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.
Microelectronic Medical Implants: Products, Technologies & Opportunities
The global market for microelectronic medical implants is expected to grow from $49.0 billion in 2024 and is projected to reach $85.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.7% during the forecast period of 2024 to 2029.
Recent Reports
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Direct-to-Consumer Genetic Testing: Global Markets and Technologies
The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.
Global Medical Tapes Market
The global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2029.
Global Prenatal Testing Market
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Global Skin Allergy Testing Market
The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More